Microdeformation mechanisms in methyl methacrylate-Glutarimide (cas 1121-89-7) random copolymers
-
Add time:10/01/2019 Source:sciencedirect.com
Transmission electron microscopy (TEM) has been used to investigate the microdeformation mechanisms in thin films (<1 μm) of MMA-glutarimide copolymers of various compositions ranging from 36 to 76 mol% glutarimide. These polymers all have an entanglement density of ∼5 × 1025 m−3, which is of the same order as that in poly(methyl methacrylate) (PMMA). Crazing is known to be the dominant deformation mechanism in thin films of PMMA tested at room temperature. As the glutarimide content is increased in the copolymers, however, motions associated with formation of shear deformation zones (DZs) are facilitated, and these become increasingly competitive with scission crazing in thin films. The presence of the MMA groups may nevertheless continue to hinder large-scale chain motions associated with high-temperature disentanglement crazing, since it was found that the absolute temperature for the onset of disentanglement in the copolymers remained similar to that in PMMA (ca. 80°C for the strain rates used here), and was essentially independent of the composition and the glass transition temperature (Tg).
We also recommend Trading Suppliers and Manufacturers of Glutarimide (cas 1121-89-7). Pls Click Website Link as below: cas 1121-89-7 suppliers
Prev:Synthesis and biological evaluation of molecular probes based on the 9-methylstreptimidone derivative DTCM-Glutarimide (cas 1121-89-7)
Next:Regioselective reduction of N-alkyl-3-sulfonyl Glutarimide (cas 1121-89-7)s to δ-lactams. Formal synthesis of (±)-paroxetine and (±)-tacamonine☆) - 【Back】【Close 】【Print】【Add to favorite 】
- Related Information
- Synthesis of actiketal, a Glutarimide (cas 1121-89-7) antibiotic09/30/2019
- Activities of 2-phthalimidethanol and 2-phthalimidethyl nitrate, phthalimide analogs devoid of the Glutarimide (cas 1121-89-7) moiety, in experimental models of inflammatory pain and edema09/29/2019
- Regioselective reduction of N-alkyl-3-sulfonyl Glutarimide (cas 1121-89-7)s to δ-lactams. Formal synthesis of (±)-paroxetine and (±)-tacamonine☆09/28/2019
- Synthesis and biological evaluation of molecular probes based on the 9-methylstreptimidone derivative DTCM-Glutarimide (cas 1121-89-7)09/27/2019
- A novel tandem process leading to functionalized Glutarimide (cas 1121-89-7)s09/26/2019
- Synthesis of fused bicyclic Glutarimide (cas 1121-89-7)s09/25/2019
- Inhibition of RANKL- and LPS-induced osteoclast differentiations by novel NF-κB inhibitor DTCM-Glutarimide (cas 1121-89-7)09/24/2019


